Expert insights. Personalized for you.
Brii Biosciences Provides Update on Strategic Clinical Development Progress Brii Biosciences Provides Update on Strategic Clinical Development Progress Company received U.S. MORE
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV – Phase 1 dose-escalation study started at clinical … Continue reading → EQS NewsfeedDGAP-News: CureVac / Key word(s): Study 30.03.2022 / 13:00 The issuer is solely responsible for the content of this announcement. MORE
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines — Curevo’s lead program is CRV-101, … Continue reading → Business Wire MORE
Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights On Track to Initiate … Continue reading → Business Wire MORE
Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances. Clinical Development MORE
Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan U.S. FDA clears IND to evaluate MET642 for the treatment of ulcerative colitis Sufficient capital to complete Phase 2 IBD … Continue reading → GlobeNewswire MORE
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience Bernard Coulie, M.D., MORE
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Announced positive topline data from EQUATE … Continue reading → Business Wire MORE
Biophytis / Key word(s): Miscellaneous Biophytis provides updates on Sarconeos (BIO101) clinical development 07-Apr-2022 / 08:00 CET/CEST Biophytis provides updates on Sarconeos (BIO101)clinical development Sarcopenia (SARA) : discussions engaged with FDA for the preparation of a Phase 2-3 program … Continue reading → EQS Newsfeed MORE
Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT – New next-gen SPEAR … Continue reading → GlobeNewswire MORE
Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease – Single pivotal trial to initiate later this month targets the broad patient population … Continue reading → Business Wire MORE
Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Key leadership appointment of Dr. Morriss enhances the company’s research … Continue reading → Business Wire MORE
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease CTA approved by Health Canada in November 2021; … Continue reading → Business Wire MORE
The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders. Clinical Development MORE
Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Successful IPO on Euronext Growth® in Paris Cash … Continue reading → Business Wire MORE
2022 Oncolytic Virotherapies Analytical Tool: A Must Have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer – ResearchAndMarkets.com 2022 Oncolytic Virotherapies Analytical Tool: A Must Have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer – ResearchAndMarkets.com … Continue reading → Business Wire MORE
Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. Novavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K. MORE
Hence, the next clinical milestone will very likely be the development of allogeneic CART therapies that could offer off-the-shelf products with immediate availability as an on-demand therapeutic option for patients with high unmet medical needs. Meeting Clinical Objectives. MORE
CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations BEIJING & CAMBRIDGE, Mass.–(BUSINESS MORE
Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205 Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205 Response to pre-IND briefing package supports pathway to initiating a Phase 1 … Continue reading → GlobeNewswire MORE
AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. Their lead programme ATX01 is in clinical development in Chemotherapy-Induced Peripheral Neuropathy. 15, 2020 07:15 UTC. MORE
Clinical DevelopmentThe two-day Oracle Health Sciences Connect will gather an array of research experts to discuss how to make the most of emerging technologies and practices. MORE
Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing MORE
Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME MORE
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance MORE
Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights On Track to Meet Multiple Clinical Milestones for AU-011 in … Continue reading → Business Wire MORE
Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development Press Release Nicox Appoints Doug Hubatsch as new Chief Scientific … Continue reading → GlobeNewswire MORE
to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on May 10, 2022 Reata Pharmaceuticals, Inc. to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical … Continue reading → Business Wire MORE
Nimbus Therapeutics Strengthens Clinical Development Leadership Team Nimbus Therapeutics Strengthens Clinical Development Leadership Team CAMBRIDGE, Mass.–(BUSINESS MORE
Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE – Company plans to focus development of Zygel™ in FXS, ASD and 22q – – Company … Continue reading → GlobeNewswire MORE
ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments EVANSTON, Ill.–(BUSINESS MORE
Clinical Development Related Topics 
Outsourcing Pharma
APRIL 7, 2022
Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances. Clinical Development
BioTech 365
APRIL 13, 2022
Nimbus Therapeutics Strengthens Clinical Development Leadership Team Nimbus Therapeutics Strengthens Clinical Development Leadership Team CAMBRIDGE, Mass.–(BUSINESS
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
MARCH 24, 2022
The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders. Clinical Development
Bio Pharma Dive
FEBRUARY 1, 2021
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance
BioTech 365
MAY 11, 2022
CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations CANbridge Pharmaceuticals Appoints Pauline Li as Senior Vice President of Clinical Development and Operations BEIJING & CAMBRIDGE, Mass.–(BUSINESS
BioTech 365
APRIL 6, 2022
Biophytis / Key word(s): Miscellaneous Biophytis provides updates on Sarconeos (BIO101) clinical development 07-Apr-2022 / 08:00 CET/CEST Biophytis provides updates on Sarconeos (BIO101)clinical development Sarcopenia (SARA) : discussions engaged with FDA for the preparation of a Phase 2-3 program … Continue reading → EQS Newsfeed
BioPharma Reporter
OCTOBER 11, 2021
Samsung Biologics and Enzolytics have entered into a strategic CDMO partnership agreement targeting monoclonal antibody production. Upstream Processing
BioTech 365
MAY 16, 2022
Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT – New next-gen SPEAR … Continue reading → GlobeNewswire
BioTech 365
MARCH 22, 2022
Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease – Single pivotal trial to initiate later this month targets the broad patient population … Continue reading → Business Wire
BioSpace
JULY 22, 2021
Shares of Adverum Biotechnologies plunged more than 20% in premarket trading after the company announced it was revising its clinical development plan for investigational gene therapy candidate ADVM-022 based on safety concerns in patients with diabetic macular edema (DME
BioTech 365
FEBRUARY 11, 2022
Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring Plan U.S. FDA clears IND to evaluate MET642 for the treatment of ulcerative colitis Sufficient capital to complete Phase 2 IBD … Continue reading → GlobeNewswire
|
BioTech 365
MAY 17, 2021
Brii Biosciences Provides Update on Strategic Clinical Development Progress Brii Biosciences Provides Update on Strategic Clinical Development Progress Company received U.S.
BioTech 365
MARCH 30, 2022
Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development Successful IPO on Euronext Growth® in Paris Cash … Continue reading → Business Wire
BioTech 365
MAY 6, 2022
2022 Oncolytic Virotherapies Analytical Tool: A Must Have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer – ResearchAndMarkets.com 2022 Oncolytic Virotherapies Analytical Tool: A Must Have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer – ResearchAndMarkets.com … Continue reading → Business Wire
BioTech 365
DECEMBER 16, 2021
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118 for the Treatment of CLN1 Disease CTA approved by Health Canada in November 2021; … Continue reading → Business Wire
BioTech 365
DECEMBER 15, 2020
BioTech 365
MARCH 23, 2022
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates Announced positive topline data from EQUATE … Continue reading → Business Wire
BioTech 365
NOVEMBER 10, 2021
The Pharma Data
NOVEMBER 30, 2020
Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its COVID-19 vaccine program. Novavax completed enrollment of 15,000 participants in a pivotal Phase 3 clinical trial being conducted in the U.K.
BioTech 365
FEBRUARY 10, 2022
Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines — Curevo’s lead program is CRV-101, … Continue reading → Business Wire
BioTech 365
SEPTEMBER 29, 2021
BioTech 365
AUGUST 31, 2021
BioTech 365
MARCH 30, 2022
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV – Phase 1 dose-escalation study started at clinical … Continue reading → EQS NewsfeedDGAP-News: CureVac / Key word(s): Study 30.03.2022 / 13:00 The issuer is solely responsible for the content of this announcement.
BioTech 365
MAY 2, 2022
to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on May 10, 2022 Reata Pharmaceuticals, Inc. to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical … Continue reading → Business Wire
BioTech 365
AUGUST 17, 2021
ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments ZS Announces Exclusive Partnership with Intelligencia to Reduce Risk in Clinical Development and Guide Portfolio Investments EVANSTON, Ill.–(BUSINESS
BioTech 365
AUGUST 10, 2021
BioTech 365
JULY 29, 2021
CATO Research
JANUARY 20, 2022
Hence, the next clinical milestone will very likely be the development of allogeneic CART therapies that could offer off-the-shelf products with immediate availability as an on-demand therapeutic option for patients with high unmet medical needs. Meeting Clinical Objectives.
BioTech 365
JULY 13, 2021
Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development Key leadership appointment of Dr. Morriss enhances the company’s research … Continue reading → Business Wire
BioTech 365
JULY 1, 2021
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience Bernard Coulie, M.D.,
The Pharma Data
DECEMBER 14, 2020
AlgoTherapeutix recently raised a 12M€ Series A that will fund the Phase 1 and 2 clinical development of ATX01. Their lead programme ATX01 is in clinical development in Chemotherapy-Induced Peripheral Neuropathy. 15, 2020 07:15 UTC.
BioTech 365
JANUARY 6, 2022
Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205 Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19 Antiviral CDI-45205 Response to pre-IND briefing package supports pathway to initiating a Phase 1 … Continue reading → GlobeNewswire
BioTech 365
JANUARY 4, 2022
Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE Zynerba Pharmaceuticals Announces Clinical Development Updates for FXS, ASD, 22q and DEE – Company plans to focus development of Zygel™ in FXS, ASD and 22q – – Company … Continue reading → GlobeNewswire
Outsourcing Pharma
APRIL 20, 2022
Clinical DevelopmentThe two-day Oracle Health Sciences Connect will gather an array of research experts to discuss how to make the most of emerging technologies and practices.
BioTech 365
MARCH 23, 2022
Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights Aura Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights On Track to Initiate … Continue reading → Business Wire
BioTech 365
DECEMBER 13, 2021
Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-clinical Development Press Release Nicox Appoints Doug Hubatsch as new Chief Scientific … Continue reading → GlobeNewswire
52 
Let's personalize your content